Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice
Ivana De Domenico, … , Diane M. Ward, Jerry Kaplan
Ivana De Domenico, … , Diane M. Ward, Jerry Kaplan
Published June 7, 2010
Citation Information: J Clin Invest. 2010;120(7):2395-2405. https://doi.org/10.1172/JCI42011.
View: Text | PDF | Corrigendum
Research Article Inflammation Article has an altmetric score of 9

Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice

  • Text
  • PDF
Abstract

Hepcidin is a peptide hormone that regulates iron homeostasis and acts as an antimicrobial peptide. It is expressed and secreted by a variety of cell types in response to iron loading and inflammation. Hepcidin mediates iron homeostasis by binding to the iron exporter ferroportin, inducing its internalization and degradation via activation of the protein kinase Jak2 and the subsequent phosphorylation of ferroportin. Here we have shown that hepcidin-activated Jak2 also phosphorylates the transcription factor Stat3, resulting in a transcriptional response. Hepcidin treatment of ferroportin-expressing mouse macrophages showed changes in mRNA expression levels of a wide variety of genes. The changes in transcript levels for half of these genes were a direct effect of hepcidin, as shown by cycloheximide insensitivity, and dependent on the presence of Stat3. Hepcidin-mediated transcriptional changes modulated LPS-induced transcription in both cultured macrophages and in vivo mouse models, as demonstrated by suppression of IL-6 and TNF-α transcript and secreted protein. Hepcidin-mediated transcription in mice also suppressed toxicity and morbidity due to single doses of LPS, poly(I:C), and turpentine, which is used to model chronic inflammatory disease. Most notably, we demonstrated that hepcidin pretreatment protected mice from a lethal dose of LPS and that hepcidin-knockout mice could be rescued from LPS toxicity by injection of hepcidin. The results of our study suggest a new function for hepcidin in modulating acute inflammatory responses.

Authors

Ivana De Domenico, Tian Y. Zhang, Curry L. Koening, Ryan W. Branch, Nyall London, Eric Lo, Raymond A. Daynes, James P. Kushner, Dean Li, Diane M. Ward, Jerry Kaplan

×

Figure 5

Effect of a high-iron diet on LPS-injected wild-type and Hamp–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
Effect of a high-iron diet on LPS-injected wild-type and Hamp–/– mice.
 ...
(A) Six C57BL/6 and (B) 6 Hamp–/– mice maintained on a high-iron diet for 2 days were given an intraperitoneal injection of PBS or LPS (1 mg/kg). After 4 hours mice were sacrificed, and mRNA was extracted from liver and spleen. Liver mRNAs for Tnfa, Il6, Il7, Il17r, and Sos3 were analyzed by RT-PCR. (C) Five C57BL/6 mice were treated with an intraperitoneal injection of PBS or hepcidin (100 μg/mouse). Two hours after hepcidin/PBS injection, mice were given an intraperitoneal injection of PBS, poly(I:C) (100 μg/mouse), or turpentine (100 μl/mouse). After 4 hours mice were sacrificed, sera isolated, and TNF-α and IL-6 (pg/ml serum) levels were measured. (D) Fifteen C57BL/6 mice were subjected to CLP and treated with hepcidin or saline, and IL-6 levels (pg/ml serum) were assayed. *P = 0.039, **P = 0.068, ***P = 0.015. (E) Survival of the mice treated in D was determined. The survival data were plotted as a Kaplan-Meier plot.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
Referenced in 1 Wikipedia pages
112 readers on Mendeley
See more details